Department of Reconstructive Plastic Surgery, Karolinska University Hospital, Sweden.
Department of Reconstructive Plastic Surgery, Karolinska University Hospital, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, SE-17177, Stockholm, Sweden.
Injury. 2020 Dec;51 Suppl 4:S108-S113. doi: 10.1016/j.injury.2020.02.110. Epub 2020 Feb 22.
Lymphaticovenular anastomosis (LVA) with supramicrosurgical technique has recently gained popularity as a treatment method for patients with lymphedema. The aim of this study was to prospectively evaluate objective changes in leg volume in patients operated with LVA for lymphedema in the lower extremity, and to find positive predictors for the treatment method to facilitate the location of the venules and lymphatic vessels.
PATIENTS & METHODS: 31 consecutive patients with lymphedema in the lower extremity and positive pitting test were examined with lymphoscintigraphy and indocyanine green (ICG) lymphography. The causes of the lymphedema were either cancer or unknown cause/primary lymphedema. Fourteen of the patients with pathological lymphangiographic patterns were chosen for surgery and 12 of them were operated with one to four LVAs each. The lymphedema volume in the lower extremity was measured preoperatively, 6- and 12 months after surgery according to the truncated cone formula with the patient´s contralateral leg used as control. Ten patients had unilateral lymphedema and two patients had bilateral lymphedema.
Five of 12 patients showed between 1-8% edema reductions in the lower extremity after 12 months. With examination considering edema duration, number of anastomoses, radiotherapy and lymph node dissection we found a 6,2% difference in edema reduction between patients who had undergone lymph node dissection and those who had not (p = 0.03).
The current study indicates that supramicrosurgery with LVA may reduce edema volumes, where the most distinctive positive predictor for edema reduction with LVAs was previous lymph node dissection.
淋巴管-静脉吻合术(LVA)结合超显微外科技术最近作为一种治疗下肢淋巴水肿的方法越来越受欢迎。本研究的目的是前瞻性评估接受 LVA 手术治疗下肢淋巴水肿患者腿部体积的客观变化,并寻找治疗方法的阳性预测因子,以方便找到静脉和淋巴管。
对 31 例下肢淋巴水肿且凹陷试验阳性的患者进行淋巴闪烁显像和吲哚菁绿(ICG)淋巴管造影检查。淋巴水肿的病因是癌症或未知原因/原发性淋巴水肿。对 14 例病理淋巴管造影模式患者进行手术治疗,其中 12 例患者接受 1 至 4 次 LVA 手术。术前、术后 6 个月和 12 个月,根据患者对侧腿作为对照的截断锥公式测量下肢淋巴水肿体积。10 例患者为单侧淋巴水肿,2 例为双侧淋巴水肿。
12 例患者中有 5 例在 12 个月后下肢水肿减少 1-8%。考虑到水肿持续时间、吻合术数量、放疗和淋巴结清扫,我们发现行淋巴结清扫术与未行淋巴结清扫术的患者之间的水肿减轻程度有 6.2%的差异(p=0.03)。
本研究表明,LVA 结合超显微外科手术可能会减少水肿体积,其中 LVA 治疗水肿减轻的最显著阳性预测因子是先前的淋巴结清扫。